In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

The bacterial changes also correlate with increased antibiotic resistance, highlighting the need for better targeting of ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions ...

American Heart Association Scientific Sessions 2024, Late Breaking Science Abstract 4170722 - A study testing a new nasal ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

LUNA data combined with follow-up from OPTIC at 4 years continue to support long-term potential best-in-class product profile of ...

Until my mid-40s, my approach to gum health was, at best, sporadic. I had always suspected that flossing was one of those ...

UC is a chronic, autoimmune bowel disease that causes ulcers and inflammation in the colon and rectum ... It is typically ...

If Tylenol isn’t doing the job with pain control, then I might suggest applying topical NSAIDs like diclofenac (Voltaren).